Mar­ket­ingRx Matchup: Is it No­vo Nordisk’s Ozem­pic or Lil­ly and BI’s Jar­diance for the win in Type 2 ads?

While it’s not quite time for March Mad­ness yet, we’re warm­ing up this week with some Mar­ket­ingRx’s ad­ver­tis­ing mad­ness.

This month’s DTC matchup gauges con­sumers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.